Abstract:Purpose: Skeletal muscle dysfunction is common in patients with chronic obstructive pulmonary disease (COPD) and is associated with a poor prognosis. Abnormal muscle quantity of the lower limbs is a manifestation of skeletal muscle dysfunction in patients with COPD. Shear wave ultrasound elastography (SWE) is a novel and possible tool to evaluate qualitative muscle parameters. This study explores the feasibility of SWE to measure the stiffness of the rectus femoris and evaluates its value in predicting sarcopenia in patients with COPD. Methods: Ultrasound examination of the rectus femoris was performed to determine the mean elasticity index (SWE mean ), cross-sectional area (RF csa ), and thickness (RF thick ) using grayscale ultrasonography (US) and SWE in 53 patients with COPD and 23 age-matched non-COPD healthy controls. The serum levels of circulating biomarkers (GDF15, resistin, and TNF-α) were measured using ELISA. The definition of sarcopenia followed the guidelines from the Asian Working Group for Sarcopenia. Receiver operating characteristic (ROC) curve analysis of the SWE mean , RF thick , and RF csa was used to evaluate their predictive ability for sarcopenia. Results: The intraobserver and interobserver repeatability of SWE performance was excellent (all correlation coefficients > 0.95; p < 0.05). The SWE mean of the rectus femoris in patients with COPD (8.98 ± 3.12 kPa) was decreased compared with that in healthy controls (17.00 ± 5.14 kPa) and decreased with advanced global initiative for chronic obstructive lung disease (GOLD) stage. Furthermore, SWE mean was found to be independent of sex, height, and body mass, and a lower SWE mean in patients with COPD was positively associated with reduced pulmonary function, worse physical function, poor exercise tolerance, decreased muscle strength, and worse dyspnea index score. The correlation between physical function [five-repetition sit-to-stand test (5STST)], muscle function, and SWE mean was higher than those of RF thick and RF csa . In addition, SWE mean was negatively correlated with serum GDF15 levels ( r = −0.472, p < 0.001), serum resistin levels ( r = −0.291, p = 0.035), and serum TNF-α levels ( r = −0.433, p = 0.001). Finally, the predictive power of SWE mean [area under the curve (AUC): 0.863] in the diagnosis of sarcopenia was higher than that of RF thick (AUC: 0.802) and RF csa (AUC: 0.816). Conclusion: Compared with grayscale US, SWE was not affected by the patient’s height, weight, or BMI and better represented skeletal muscle function and physical function. Furthermore, SWE is a promising potential tool to predict sarcopenia in patients with COPD.

Multi-channel EMG manifestations of upper-extremity muscle coordination imbalance among community-dwelling sarcopenic seniors

Wearable Multichannel Electromyography Sensors for Homecare Sarcopenia Diagnosis

Development and Validation of a Screening Tool for Sarcopenia in Chinese Nursing Home Residents

Exploration of a machine learning approach for diagnosing sarcopenia among Chinese community-dwelling older adults using sEMG-based data

sEMG-based Sarcopenia risk classification using empirical mode decomposition and machine learning algorithms

Characteristics of the Electrophysiological Properties of Neuromuscular Motor Units and Its Adaptive Strategy Response in Lower Extremity Muscles for Seniors with Pre-Sarcopenia: A Preliminary Study

A Combination of Serum Biomarkers in Elderly Patients with Sarcopenia: A Cross-Sectional Observational Study

Detecting muscle fatigue among community-dwelling senior adults with shape features of the probability density function of sEMG

Digital Biomarker for Muscle Function Assessment Using Surface Electromyography With Electrical Stimulation and a Non-Invasive Wearable Device

Comparative Analysis of Supervised Classifiers for the Evaluation of Sarcopenia Using a sEMG-Based Platform

Machine and deep learning-based clinical characteristics and laboratory markers for the prediction of sarcopenia

High Accuracy Machine Learning Model for Sarcopenia Severity Diagnosis based on Sit-to-stand Motion Measured by Two Micro Motion Sensors

Feasibility of Sarcopenia Diagnosis Using Stimulated Muscle Contraction Signal in Hemiplegic Stroke Patients

State of the art of quantitative measurement of sarcopenia

Portable Digital Monitoring System for Sarcopenia Screening and Diagnosis

Development of sarcopenia assessment system using balance and gait ability: Preliminary tests in the elderly

Predict Sarcopenia Risk in the Elderly by Cardiovascular Function and Heart Rate Variability

Comparison of different MRI-based unsupervised segmentation algorithms in predicting sarcopenia

Evaluation of the Accuracy of Six Simple Screening Tools for Sarcopenia in Schizophrenic Patients

Sonographic methods to predict type 2 diabetes patients with sarcopenia: B mode ultrasound and shear wave elastography

Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease